Between September 2 and 9, 2014, there have been 31 more cases of Ebola virus disease (EVD) reported in the Democratic Republic of the Congo (DRC), increasing the cumulative number of cases to 62 (14 confirmed, 26 probable, and 22 suspect). In total, 35 deaths have been reported (9 confirmed and 26 probable). No deaths have been reported among suspected cases. Nine healthcare workers have been diagnosed with EVD, including 7 deaths. All the cases have been localized in Jeera county. The affected villages are Watsi Kengo, Lokolia, Boende, and Boende Muke. Currently, 9 cases have been hospitalized: 4 in Lokolia; 2 in Watsikengo; 2 in Boende; and 1 in Boende Moke. A total of 386 contacts have been listed and 239 contacts have been followed-up. All cases and contacts are linked to the initial index case reported to the World Health Organization (WHO) on Aug. 26, 2014.
During a regional meeting between the Ministry of Health of DRC and the Southern African Development Community on the management and prevention of EVD transmission, the following measures were recommended: standardization of the interventions for the prevention of EVD and enhancement of sanitary border control without impeding international traffic.
Under the leadership of the government, the international community is providing strong logistical support and sending experts, equipment, food, and transportation means to the field.
A team of national and international specialists have been deployed to work with the local response teams. Patients are being treated in temporary isolation units in Watsi Kengo, Lokolia, Boende, and Boende Muke. A mobile laboratory from the National Institute of Biomedical Research (INRB) has been installed in Lokolia and is currently functional. Two laboratory epidemiologists from the US Centers for Disease Control and Prevention have arrived in DRC to support the INRB field team.
Contact tracing activities are being carried out by an assigned team with supervision from of a medical epidemiologist and a community worker, and when required, psychologists visit and dialogue with communities. Ongoing sensitization activities to mobilize community leaders are being implemented.
The WHO does not recommend any travel or trade restrictions be applied except in cases where individuals have been confirmed or are suspected of being infected with EVD or where individuals have had contact with cases of EVD. (Contacts do not include properly-protected healthcare workers and laboratory staff.)
Source: WHO
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.